Description

VOVERAN SR 100 MG TAB

Indications

VOVERAN SR 100 MG TAB is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used to alleviate postoperative pain and pain associated with dental procedures. The sustained-release formulation allows for prolonged therapeutic effects, making it suitable for patients requiring long-term pain management.

Mechanism of Action

VOVERAN contains diclofenac sodium as its active ingredient, which is a non-steroidal anti-inflammatory drug (NSAID). The primary mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By blocking these enzymes, diclofenac reduces the synthesis of prostaglandins, which are compounds that mediate inflammation, pain, and fever. This results in decreased inflammation and pain relief in affected tissues.

Pharmacological Properties

Diclofenac sodium is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 2 to 4 hours after oral administration. The sustained-release formulation of VOVERAN ensures a gradual release of the drug, allowing for a longer duration of action. The elimination half-life of diclofenac is approximately 1 to 2 hours, but the sustained-release formulation extends its therapeutic effects. The drug is extensively metabolized in the liver, and its metabolites are primarily excreted via the kidneys. The pharmacokinetics of diclofenac can be influenced by factors such as age, liver function, and concurrent medications.

Contraindications

VOVERAN SR 100 MG TAB is contraindicated in patients with a known hypersensitivity to diclofenac or any of its excipients. It should not be used in individuals with a history of gastrointestinal bleeding or perforation related to previous NSAID therapy. Patients with severe heart failure, active peptic ulcer disease, or significant renal impairment should also avoid this medication. Additionally, VOVERAN is contraindicated during the third trimester of pregnancy due to potential risks to the fetus.

Side Effects

Common side effects of VOVERAN SR may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Other potential side effects include dizziness, headache, and skin rashes. Serious adverse effects, although rare, can occur and may include liver toxicity, renal impairment, and cardiovascular events such as myocardial infarction or stroke. Patients should be monitored for any signs of severe allergic reactions, including anaphylaxis, which may manifest as difficulty breathing, swelling of the face or throat, and hives.

Dosage and Administration

The recommended dosage of VOVERAN SR 100 MG TAB is one tablet taken orally, preferably with food, to minimize gastrointestinal irritation. The dosing frequency is typically once or twice daily, depending on the severity of the condition and the patient’s response to treatment. It is essential to adhere to the prescribed dosage and not exceed the maximum recommended daily dose to reduce the risk of adverse effects. In elderly patients or those with comorbid conditions, dosage adjustments may be necessary based on individual tolerability and response.

Interactions

VOVERAN SR may interact with several medications, potentially altering their effects or increasing the risk of adverse reactions. Concurrent use with other NSAIDs or anticoagulants such as warfarin can increase the risk of gastrointestinal bleeding. Additionally, the co-administration of diuretics or antihypertensive agents may diminish their effectiveness due to the sodium-retaining properties of NSAIDs. It is crucial for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with VOVERAN SR, a thorough medical history should be obtained, particularly concerning any history of gastrointestinal disorders, cardiovascular disease, or renal impairment. Patients with a history of asthma or allergic reactions to NSAIDs should use this medication with caution. Regular monitoring of renal function and liver enzymes may be warranted during prolonged therapy, especially in patients with pre-existing conditions. Patients should be advised to report any unusual symptoms or side effects promptly.

Clinical Studies

Clinical studies have demonstrated the efficacy of diclofenac in reducing pain and inflammation in various conditions. A randomized controlled trial published in the Journal of Rheumatology showed that patients with osteoarthritis experienced significant pain relief and improved function after treatment with diclofenac compared to placebo. Another study in the British Medical Journal highlighted the effectiveness of diclofenac in managing postoperative pain, with patients reporting lower pain scores and reduced need for additional analgesics. These studies support the use of VOVERAN SR as a viable option for managing chronic pain and inflammation.

Conclusion

VOVERAN SR 100 MG TAB is a valuable therapeutic option for patients suffering from pain and inflammation associated with various musculoskeletal disorders. Its sustained-release formulation provides prolonged analgesic effects, making it suitable for long-term management. However, careful consideration of contraindications, potential side effects, and drug interactions is essential to ensure safe and effective use. Patients should engage in open communication with their healthcare providers to optimize their treatment outcomes and address any concerns regarding their therapy.